Category: Pharmaceuticals

Pharmaceuticals • 28.04.25

Merck Acquires US Cancer Specialist Springworks in $3 Billion Deal

Merck acquires Springworks Therapeutics for $3 billion, boosting its oncology pipeline with innovative cancer treatments. A game-changer for rare disease therapies.

StockTimes Content Team

1
Cryptocurrency • 08.04.25

SOL Strategies Expands Solana Staking with Major SOL Purchase

StockTimes Content Team
Cryptocurrency • 23.10.25

WazirX Rises from the Ashes: A Phoenix Story in India's Crypto Landscape

StockTimes Content Team
Finance • 06.03.25

Marvell Technology's Stock Plunge: A Deep Dive into the Chipmaker's Disappointing Outlook

StockTimes Content Team
Investing • 18.10.25

The Buffett Doctrine: Why Productive Assets Trump "Sterile" Gold

StockTimes Content Team
Business • 12.04.25

Meta Expands Board with Former Trump Advisor and Stripe CEO: A Strategic Shift?

StockTimes Content Team
Cryptocurrency • 19.10.25

XRP and SOL Forge Their Own Path: A Bullish Options Divergence Emerges

StockTimes Content Team

Categories

Tags